- Maj M.
- Keck Jr, P.E.
- McElroy S.L.
- Strakowski S.M.
- West S.A.
- Sax K.W.
- Hawkins J.M.
- et al.
- Murray C.J.L.
- Lopez A.D.
- Coryell W.
- Scheftner W.
- Keller M.
- Endicott J.
- Maser J.
- Klerman G.L.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Biological Psychiatry
- A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression.J Clin Psychiatry. 1999; 60: 79-88
- The enduring psychosocial consequences of mania and depression.Am J Psychiatry. 1993; 150: 720-727
- Interpersonal and social rhythm therapy.Biol Psychiatry. 2000; 48: 593-604
- Twelve-month outcome of bipolar patients following hospitalization for a manic or mixed episode.Am J Psychiatry. 1998; 155: 646-652
Leverich GS, Nolen W, Rush AJ, McElroy SL, Keck PE Jr, Denicoff KD, et al (in press): The Stanley Foundation Bipolar Treatment Outcome Network: I. Longitudinal methodology. J Affect Disord.
- The impact of lithium prophylaxis on the course of bipolar disorder.Bipolar Disord. 2000; 2: 93-101
- Family-focused treatment of bipolar disorder.Biol Psychiatry. 2000; 48: 582-592
- The Global Burden of Disease Summary. Harvard School of Public Health, Cambridge, MA1996
Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP (in press): A double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry.
Sachs GS, Risperidone Study Group (1999, December): Safety and efficacy of risperidone vs placebo as add-on therapy to mood stabilizers in the treatment of manic phase of bipolar disorder. Abstract presented at the 38th annual meeting of the American College of Neuropsychopharmacology, Acapulco.
Sachs GS, Thase ME, Leahy L, Gaughan SR, Lavori P, Conley J, et al (2000, May): The Systematic Treatment Enhancement Program for Bipolar Disorder. Abstract presented at the annual meeting of the American Psychiatric Association, Chicago.
Tohen M, Jacobs TG, Meyers TM, Risser RC, Keeter EL, Breier PD (2000, May): Efficacy of olanzapine combined with mood stabilizers in the treatment of bipolar disorder. Abstract presented at the annual meeting of the American Psychiatric Association, Chicago.